Related Experiment Video
Updated: May 9, 2026
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
CT- and MRI-based seed localization in postimplant evaluation after prostate brachytherapy
Marisol De Brabandere1, Bashar Al-Qaisieh, Liesbeth De Wever
1Department of Radiation Oncology, University Hospital Gasthuisberg, Leuven, Belgium.
Purpose:
To compare the uncertainties in CT- and MRI-based seed reconstruction in postimplant evaluation after prostate seed brachytherapy in terms of interobserver variability and quantify the impact of seed detection variability on a selection of dosimetric parameters for three postplan techniques: (1) CT, (2) MRI-T1 weighted fused with MRI-T2 weighted, and (3) CT fused with MRI-T2 weighted.
Methods And Materials:
Seven physicists reconstructed the seed positions on postimplant CT and MRI-T1 images of three patients. For each patient and imaging modality, the interobserver variability was calculated with respect to a reference seed set. The effect of this variability on dosimetry was calculated for CT and CT + MRI-T2 (CT-based seed reconstruction), as well as for MRI-T1 + MRI-T2 (MRI-T1-based seed reconstruction), using fixed CT and MRI-T2 prostate contours.
Results:
Averaged over three patients, the interobserver variability in CT-based seed reconstruction was 1.1 mm (1 SDref, i.e., standard deviation with respect to the reference value). The D90 (dose delivered to 90% of the target) variability was 1.5% and 1.3% (1 SDref) for CT and CT + MRI-T2, respectively. The mean interobserver variability in MRI-based seed reconstruction was 3.0 mm (1 SDref), and the impact of this variability on D90 was 6.6% for MRI-T1 + MRI-T2.
Conclusions:
Seed reconstruction on MRI-T1-weighted images was less accurate than on CT. This difference in uncertainties should be weighted against uncertainties due to contouring and image fusion when comparing the overall reliability of postplan techniques.
